SCHEMBL7902140

SCHEMBL7902140

Cc1cc(O)ccc1N(CCO)CCO

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
ESR2 Q92731 6/20 0.40
ESR1 P03372 5/20 0.36
CYP3A4 P08684 2/20 0.35
CHRM1 P11229 1/20 0.35
ALOX15 P16050 1/20 0.35
MAOA P21397 1/20 0.35
TBXA2R P21731 1/20 0.35
ADRA1A P35348 1/20 0.35
HTR2B P41595 1/20 0.35
TSHR P16473 1/20 0.35
RECQL P46063 1/20 0.35
HSD17B1 P14061 1/20 0.35
ACHE P22303 1/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
GAA P10253 2/20 0.34
MCL1 Q07820 2/20 0.34
LMNA P02545 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28924534 0.85 ALDH1A1 (0.55) ALDH1A1ESR2ESR1CYP3A4ALOX15
SCHEMBL7903843 0.83 CYP3A4 (0.39) ALDH1A1ESR2ESR1CYP3A4CHRM1
SCHEMBL380688 0.82 ALDH1A1 (0.45) ALDH1A1MAPTMEN1KMT2AGAA
Hydrochloric Acid SCHEMBL7902755 0.81 CYP3A4 (0.38) ESR2ESR1CYP3A4CHRM1ALOX15
SCHEMBL855950 0.79 PDE10A (0.44) ALDH1A1CYP3A4ALOX15TSHRACHE
SCHEMBL2290043 0.77 ESR1 (0.36) ALDH1A1ESR2ESR1CYP3A4MAPT
SCHEMBL7530175 0.76 ALDH1A1 (0.42) ALDH1A1CYP3A4ALOX15TSHRRECQL
SCHEMBL11792307 0.75 ALDH1A1 (0.49) ALDH1A1MAPTMEN1KMT2AGAA
SCHEMBL19594987 0.75 ALDH1A1 (0.50) ALDH1A1TSHRMEN1KMT2ARAB9A
SCHEMBL628764 0.74 ALOX5 (0.41) ESR2ESR1CYP3A4TSHRRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277880-B1 ANTIBODY DIRECTED ENZYME PRODUG THERAPY ZENECA LIMITED (GB) 2001-08-21 US disclosed
US-5958971-A PRODRUGS OF NITROGEN MUSTARD, AN ANTICARCINOGENIC AND TUMOR AGENT; ANTIBODY DIRECTED ENZYME PRODRUG THERAPY (ADEPT); BIOCHEMICAL CONJUGATION ZENECA LIMITED (GB) 1999-09-28 US disclosed
EP-0651740-B1 AMINO ACID LINKED NITROGEN MUSTARD DERIVATIVES AND THEIR USE AS PRODRUGS IN THE TREATMENT OF TUMOURS ZENECA LTD (GB) 1998-10-21 EP disclosed
US-5660829-A DEESTERIFYING COMPOUND TO FORM N-(4(N,N-BIS(2-CHLOROETHYL) AMINO)PHENOXYCARBONYL)-L-GLUTAMIC ACID-GAMMA-(3,5-DICARBOXY)ANILIDE ZENECA LIMITED (GB) 1997-08-26 US disclosed
US-5587161-A TWO COMPONENT SYSTEM INCLUDING ANTIBODY OR ANTIGEN BINDING FRAGMENT CONJUGATED TO CARBOXYPEPTIDASE G ENZYME, COMPOUND CONVERTIBLE TO CYTOTOXIC DRUG UNDER INFLUENCE OF ENZYME ZENECA LIMITED (GB) 1996-12-24 US disclosed
US-5405990-A For use in antibody directed enzyme prodrug therapy; cytotoxic parent nitrogen mustard; antitumor agents ZENECA LIMITED (GB) 1995-04-11 US disclosed